29th week of 2011 patent applcation highlights part 45 |
Patent application number | Title | Published |
20110178136 | HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF - Disclosed are amino acid and phosphate prodrugs of compounds of the Formula V | 2011-07-21 |
20110178137 | DIARYL UREA FOR TREATING HEART FAILURE - The present invention relates to pharmaceutical compositions and combinations for treating, preventing or managing heart failure and/or connected diseases therewith comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide optionally combined with at least one additional therapeutic agent. | 2011-07-21 |
20110178138 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES - The present invention is directed to novel compounds. These compounds can be useful in inhibiting the activity of protein prenyltransferases including GGTase I and/or RabGGTase. The compounds can also be used as anti-cancer therapeutics including as part of methods for treating cancer, in assays, and in kits. | 2011-07-21 |
20110178139 | Pyridoxamine for the Treatment of Diabetic Kidney Disease - The present invention provides pharmaceutical compositions comprising dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier, and methods for their use in limiting the progression of renal disease and/or diabetic complications in human diabetic patient. | 2011-07-21 |
20110178140 | SULFUR CONTAINING PYRAZOLE-HETEROCYCLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS - A novel sulfur containing heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB | 2011-07-21 |
20110178141 | Thiazoliums and Their Use for Treating Protein Aging Associated Diseases - The present invention relates to a composition of a thiazolium compound of formula I or a solvate thereof, wherein the definitions of groups in the formula I are as those given in the claims: | 2011-07-21 |
20110178142 | PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC OR PROPHYLACTIC TREATMENT OF BACTERIAL INFECTIONS AND ASSOCIATED DISEASES - The present invention provides a pharmaceutical composition comprising 3-{5-[4-Oxo-2-thioxo-3-(3-trifluoromethyl-phenyl)-thiazolidin-5-ylidenemethyl]-furan-2-yl}-benzoic acid or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable excipients for therapeutic or prophylactic treatment of bacterial infections and diseases associated thereof. | 2011-07-21 |
20110178143 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound having a structure | 2011-07-21 |
20110178144 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound having a structure | 2011-07-21 |
20110178145 | ALPHA-2 ADRENERGIC AGONIST HAVING LONG DURATION OFINTRAOCULAR PRESSURE-LOWERING EFFECT - The present invention provides a method of lowering intraocular pressure which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin-2-ylamino)benzimidazole, or a salt thereof to the affected eye of a patient, as a single dose, wherein the affected eye has an intraocular pressure less than the baseline intraocular pressure for at least eight (8) hours. | 2011-07-21 |
20110178146 | THIOPHENE-CARBOXAMIDES USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 2011-07-21 |
20110178147 | COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION - The disclosure provides a composition for controlling pupil dilation comprising about 0.001% to about 1.0% by weight of an alpha-adrenergic receptor antagonist selected from phentolamine, phentolamine mesylate, or a phentolamine salt; and at least one excipient selected from the group consisting of a buffer, tonicity agent, preservative, antioxidant, surfactant, solubilizer, cosolvent, and a combination thereof. A method of controlling pupil dilation in a subject in need thereof, comprising administering a therapeutically effective amount of the composition is also provided. | 2011-07-21 |
20110178148 | SUBSTITUTED 5-VINYLPHENYL-1-PHENYL-PYRAZOLE CANNABINOID MODULATORS - This invention is directed to a cannabinoid modulator compound of formula (I): | 2011-07-21 |
20110178149 | Ether Compounds with Nitrogen-Containing 5-Member Heterocycle and Uses Thereof - The invention relates to ether compounds with nitrogen-containing 5-member heterocycle, represented by formula (I): | 2011-07-21 |
20110178150 | Use of Indole Derivatives as NURR-1 Activators for Treating Parkinson's Disease - The present invention relates to a compound derived from indole, especially a therapeutically useful compound, characterized in that it is selected from compounds of formula (I) | 2011-07-21 |
20110178151 | COMPOUNDS AND METHODS OF TREATING OBESITY - The present invention relates to novel fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as agents for the treatment of obesity and related disorders, and for improving cognition. | 2011-07-21 |
20110178152 | COMPOSITION COMPRISING S-ALLYLMERCAPTO-N-ACETYLCYSTEINE (ASSNAC) FOR UP-REGULATION OF CELLULAR GLUTATHIONE LEVEL - The present invention relates to S-allylmercapto-N-acetylcysteine (ASSNAC) and its pharmaceutically acceptable salts and solvates, which are useful for up-regulation of cellular glutathione levels and expression of phase II detoxifying enzymes. The invention further provides methods of use thereof in the prevention, alleviation or treatment of oxidative stress induced by reactive oxygen species (ROS). | 2011-07-21 |
20110178153 | METHODS OF TREATING CHEMORESISTANCE AND RELAPSE IN CANCER CELLS - Methods of treating or preventing chemoresistance or relapse growth of cancer cells are provided. Methods of treating or preventing resistance to tyrosine kinase based chemotherapeutic treatment in hematologic and solid tumors are provided. BCR-ABL drug resistance in chronic myelogenous leukemia (CML) and models for conducting further study on the same are presented. The methods comprise administering a therapeutically effective amount of one or more SIRT1 modulators to the cells or subject in need thereof. The methods may be administered in combination with, prior to or subsequent to chemotherapy or may be administered to counteract the effect of a spontaneous genetic mutation. Methods of using SIRT1 inhibitors to treat or prevent insulin and transferrin-induced resistance are also presented. A novel cell model to study mechanisms of acquired chemoresistance is also provided. | 2011-07-21 |
20110178154 | GENE EXPRESSION PROFILE THAT PREDICTS OVARIAN CANCER SUBJECT RESPONSE TO CHEMOTHERAPY - A gene profiling signature is disclosed herein. The gene signature can predict whether a subject with ovarian cancer will be chemorefractory, chemoresistant or chemosensitive. Thus, methods are disclosed for determining whether a subject with ovarian cancer is sensitive to treatment with a chemotherapeutic agent. Methods are also provided for increasing sensitivity to the chemotherapeutic agent if the presence of differential expression indicates that the ovarian cancer has a decreased sensitivity to chemotherapeutic agent. | 2011-07-21 |
20110178155 | SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA - The present invention provides compositions comprising nucleic acids that target CSN5 gene expression and methods of using such compositions to silence CSN5 gene expression. More particularly, the present invention provides unmodified and chemically modified interfering RNA molecules which silence CSN5 gene expression and methods of use thereof, e.g., for treating cell proliferative disorders such as cancer. The present invention also provides nucleic acid-lipid particles that target CSN5 gene expression comprising an interfering RNA molecule, a cationic lipid, a non-cationic lipid, and optionally a conjugated lipid that inhibits aggregation of particles. | 2011-07-21 |
20110178156 | Method of suppressing pRb deficiency-induced tumor formation - The present invention provides methods of determining a putative agent that inhibits tumorigenesis in retinoblastoma protein deficient cells, the methods comprising determining whether the putative agent decreases phosphorylation of threonine residue 187 of p27, decreases S-phase kinase-associated protein 2 interaction with p27 having a phosphorylated threonine residue 187, or an increase in apoptosis of retinoblastoma protein deficient cells. The present invention also provides the agent, the pharmaceutical composition, and methods of inhibiting, preventing and treating tumorigenesis in retinoblastoma deficient cells, the method comprising administration of the agent that decreases phosphorylation of threonine residue 187 of p27 or the S-phase kinase-associated protein 2 interaction with p27 having a phosphorylated threonine residue 187. | 2011-07-21 |
20110178157 | MODULATION OF HSP47 EXPRESSION - Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis. | 2011-07-21 |
20110178158 | Set of Antiangiogenic Molecules and Use Thereof - The present invention relates to an antiangiogenic pharmaceutical composition comprising at least one molecule selected from the group comprising an antisense nucleic acid molecule of VEGF 165, an antisense nucleic acid molecule of alpha-9 domain that forms integrin alpha-9/beta-1 and an antisense nucleic acid molecule of VAP-1, a molecule of VEGF 165-specific antibody, a molecule of antibody specific for the alpha-9 domain that forms integrin alpha-9/beta-1 and a molecule of VAP-1-specific antibody and/or combinations thereof and a pharmaceutically acceptable vehicle. The present invention also protects the use of said molecules for the production of a medicament. | 2011-07-21 |
20110178159 | INHIBITORY RNAS THAT REGULATE HEMATOPOIETIC CELLS - Provided are compositions and methods for preventing, treating, ameliorating or diagnosing conditions or diseases involving a myeloid cell proliferation disorder. Such compositions and methods target miRNA function myeloproliferative diseases. More particularly, such compositions and methods target miR-29a function in myeloid cell proliferation disorders. Also provided are methods for diagnosing risk or presence of a myeloid cell proliferation disorder in a subject. | 2011-07-21 |
20110178160 | Inhibition of Interaction of PSD93 and PSDS95 with nNOS and NMDA Receptors - PSD-95/SAP90 antisense-treated animals not only experience a significant decrease in MAC for isoflurane, but also experience an attenuation in the NMDA-induced increase in isoflurane MAC. PSD-95/SAP90 appears to mediate the role of the NMDA receptor in determining the MAC of inhalational anesthetics. Suppression of the expression of PSD-95/SAP90 in the spinal cord significantly attenuates responses to painful stimuli mediated through the N-methyl-D-aspartate receptor activation. In spinal cord neurons PSD-95/SAP90 interacts with the N-methyl-D-aspartate receptor subunits 2A/2B. Activation of the N-methyl-D-aspartate receptor in spinal hyperalgesia results in association of the N-methyl-D-aspartate receptor with PSD-95/SAP90. PSD-95/SAP90 is required for hyperalgesia triggered via the N-methyl-D-aspartate receptor at the spinal cord level. | 2011-07-21 |
20110178161 | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin - Compositions and methods for modulating tumor proliferation in an individual are provided. The methods employ nucleolin-binding agents, such as aptamers. The aptamers of the present invention can be used to modulate the proliferation of malignant, dysplastic; hyperproliferative, and/or metastatic cells through interference with molecular interactions and functions of nucleolin in the tumor cell. | 2011-07-21 |
20110178162 | TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY - Provided is a method of treating cancer in a subject by inhibiting expression of PAX2. An example of a cancer treated by the present method is prostate cancer. In the cancer treatment methods disclosed, the method of inhibiting expression of PAX2 can be by administration of a nucleic acid encoding an siRNA for PAX2. A method of treating cancer in a subject by administering DEFB1 is also provided. Similarly, provided is a method of treating cancer in a subject by increasing expression of DEFB1 in the subject. | 2011-07-21 |
20110178163 | MIR-182 IN THE DIAGNOSIS AND TREATMENT OF CANCER - The present disclosure provides methods of determining the levels of BRCA1 in a cell, altering the levels of BRCA1 in a cell, determining the likelihood of developing cancer, and determining the prognosis of a patient with cancer using miR-182 and analogs thereof. Importantly, the invention also provides methods of determining whether a patient should be treated with PARP inhibitors, improving PARP therapy in cancer, as well as methods for selecting and improving genotoxic therapies. Also featured are methods of treating patients with cancers based on the expression levels of miR-182. The invention also features compositions comprising miR-182 and analogs thereof, antagomirs of mIR-182 and analogs thereof, in combination with PARP inhibitors and genotoxic agents. | 2011-07-21 |
20110178164 | APPLICATION ON MONOOLEIN AS A NEW HELPER LIPID IN TRANSFECTION - An application of monoolein-based cationic lipid systems can be used for the complexation, transport and transfection of genetic material into target cells. The lipid systems can be prepared through the conjugation of the neutral lipid monooleoyl-rac glycerol (Monoolein) with the cationic tensioactives derived from Dioctadecyldimethylammonium (DODAX) as, for example, Dioctadecyldimethylammonium Bromide (DODAB), Dioctadecyldimethylammonium Chloride (DODAC) and Dioctadecyldimethylammonium Phosphate (DODAP). The lipofection method can present high levels of biocompatibility and reduced acquisition costs, and is applicable for molecular biology purposes ( | 2011-07-21 |
20110178165 | TETRAHYDROFURANYL SULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF - The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula (I): as defined in the specification. The invention is also directed to compositions containing the compounds of formula (I). They are useful in the treatment of CNS disorders. | 2011-07-21 |
20110178166 | METHODS OF USING LOW-DOSE DOXEPIN FOR THE IMPROVEMENT OF SLEEP - Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg). | 2011-07-21 |
20110178167 | METHOD FOR INHIBITING ACTIVITY AND/OR EXPRESSION OF MATRIX METALLOPROTEINASE, INHIBITING PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE, AND/OR PROMOTING EXPRESSION OF COLLAGEN USING TERMINALIA CATAPPA LEAF EXTRACT - A method for inhibiting the activity of matrix metalloproteinase (MMP), inhibiting the expression of matrix metalloproteinase, inhibiting the phosphorylation of mitogen-activated protein kinase (MAPK), and/or promoting the expression of collagen in a mammal is provided, and the method comprises administrating an effective amount of a | 2011-07-21 |
20110178168 | COUMARIN COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND A PROCESS FOR PREPARING THE SAME - The present invention relates to compounds of Formula (I): wherein—X and Y represent O, S, NR′; R | 2011-07-21 |
20110178169 | USE OF 5-HYDROXY-2-HYDROXYMETHYL-Y-PYRONE (HMP) AS A LEISHMANICIDAL AGENT - The present invention refers to the use of HMP (a secondary metabolite obtained from | 2011-07-21 |
20110178170 | GRISEOFULVIN ANALOGUES FOR THE TREATMENT OF CANCER BY INHIBITION OF CENTROSOMAL CLUSTERING - The present invention relates to uses of compounds having a structure as shown by formula (I) for the manufacture of a pharmaceutical composition for the treatment of cancer. Moreover, the present invention encompasses methods of treatment for said diseases. | 2011-07-21 |
20110178171 | COMPOUNDS FOR CANCER THERAPY - A method of inhibiting the cellular proliferation of at least one selected from the group consisting of androgen dependent prostate cancer cells, androgen independent prostate cancer cells, oral cancer cells, liver cancer cells (hepatoma), and gastric cancer cells in a subject is provided, wherein the method comprises administrating to the subject an effective amount of an active component selected from the group consisting of Z form isochaihulactone (Z-K8) of the following formula (I), E form isochaihulactone (E-K8) of the following formula (II), a pharmaceutically acceptable salt of Z-K8 or E-K8, a pharmaceutically acceptable ester of Z-K8 or E-K8, and combinations thereof: | 2011-07-21 |
20110178172 | Inhibitors of Carnitin-Palmitoyl-Tranferase-1 for the Treatment and prevention of disorders caused by delipidation of neural tissue - Carnitin-Palmitoyl-Transferase-1 (CPT-1) inhibitor for use in treating and/or preventing disorders caused by delipidation of neural tissue. | 2011-07-21 |
20110178173 | Anti-degradation agent - There is provided an anti-degradation agent capable of exhibiting an excellent deterioration-inhibiting property for foods, cosmetics, etc., showing a good effect even when added in a small amount, having a high heat resistance, and being free from adverse influence due to light. There are provided (1) an anti-degradation agent comprising a water-insoluble antioxidant, a water-soluble antioxidant and an emulsifying agent; and (2) an anti-degradation agent comprising a water-soluble antioxidant, and carnosol and/or carnosic acid wherein a total content of the carnosol and the carnosic acid is not less than 4% by weight. | 2011-07-21 |
20110178174 | SALTS OF TRAMADOL AND IBUPROFEN AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN - The present invention relates to salts and compositions of tramadol and ibuprofen, their crystal form, processes for preparation of the same and their uses for the treatment of pain. | 2011-07-21 |
20110178175 | METHOD FOR PRODUCING MECHANICALLY ACTIVATED AMORPHOUS AND AMORPHOCRYSTALLINE COMPOUNDS OF GLUCONIC ACID CALCIUM SALT - The invention relates to the creation of mechanically activated amorphous and amorphocrystalline compounds and compositions of a gluconic acid calcium salt, pharmaceutical preparations based thereon, a method for producing same and use for treatment of a wide range of diseases caused by disorders of calcium metabolism in an organism. A concept of the invention, as being claimed and as set forth in the application, consists in that the crystalline gluconic acid calcium salt or its compound with excipients is treated in grinding activator devices either up to the input specific energy value of not greater than 10.4 kJ/g and achieving an amorphocrystalline state or up to the input specific energy value of no less than 10.5 kJ/g and achieving an amorphous state. The obtainable agents are assessed by means of X-ray diffraction, IR, NMR, EPR spectroscopy, mass- or chromato-mass-spectrometry, and a differential thermal analysis. The mechanically activated amorphous and amorphocrystalline compounds and compositions are used as an active principle for preparing pharmaceutical preparations used for therapeutic, therapeutic-preventive and hygienic purposes. The pharmaceutical preparations comprising a therapeutically effective amount of active ingredient are used perorally 1-6 times daily, in dosages of 0.2-6 g, a course of at least 1 month. The invention can be used in medical and food industries in the production of biologically active agents, therapeutic-prophylactic means, medicinals and in practical medicine in treatment of acute osseous, dental and other diseases related to disorders of calcium metabolism in the organism. | 2011-07-21 |
20110178176 | USE OF A VIRUCIDAL PREPARATION ON AN AREA OF THE FACE FOR PREVENTION OF TRANSMISSION OR CONTRACTION OF VIRAL ILLNESSES, OR TO SHORTEN THE DURATION OF, OR LESSEN THE SEVERITY OF VIRAL ILLNESSES - A method of reducing or inhibiting the contraction or communication of viral illnesses is proposed. Application of a virucidal preparation containing one or more organic acids (e.g. malic acid) with or without a surfactant (e.g. sodium C | 2011-07-21 |
20110178177 | TOPICAL FORMULATIONS FOR TREATMENT OF NEUROPATHY - Topical treatments for neuropathy are described. The treatments include topical formulations of NMDA antagonists and one additional active ingredient. In one example, the formulation includes ketamine and gabapentin for the treatment of a subject's neuropathy. These transdermal or topical compositions provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and can be administered to subjects to treat various neuropathies. | 2011-07-21 |
20110178178 | Treatment of Motor Fluctuations - The invention relates to the use of compounds that enhance 5-hydroxytryptamine 1a receptor activity, or activation (e.g. a selective 5-hydroxytryptamine 1a receptor agonists) for preventing or reducing motor fluctuations associated with dopamine replacement therapy. | 2011-07-21 |
20110178179 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS - The present invention relates to the treatment of an individual afflicted with cognitive impairment associated with tinnitus comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative. | 2011-07-21 |
20110178180 | DEUTERIUM-ENRICHED COLCHICINE, THIOCOLCHICINE, AND DERIVATIVES THEREOF; METHODS OF PREPARATION; AND USE THEREOF - Disclosed herein are deuterium-enriched colchicine, thiocolchicine, and derivatives thereof. The deuterium-enriched compounds are useful as, an antiproliferative agent, a muscle relaxant, an anti-inflammatory agent, or an anti-gout agent. | 2011-07-21 |
20110178181 | Personal Care Compositions Comprising A Methyl Naphthalenyl Ketone Or A Derivative Thereof - A personal care composition comprising a methyl naphthalenyl ketone or a derivative thereof, such as 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2naphthalenyl)-ethan-1-one, for down regulating at least one TRP receptor associated with a pain response, including but not limited to TRPV1 and TRPA1 receptors to reduce skin irritation associated with hair removal. | 2011-07-21 |
20110178182 | ENRICHED NANOSTRUCTURE COMPOSITION - A method of producing a nanostructure composition from a solid powder is disclosed. The method comprises: (a) heating the solid powder, thereby providing a heated solid powder; (b) immersing the heated solid powder in a liquid in the presence of a gas medium, the liquid being colder than the heated powder, and (c) irradiating the cold liquid, the heated solid powder and the gas medium by electromagnetic radiation selected such that nanostructures are formed from particles of the solid powder and a stable gas phase is formed from the gas medium. | 2011-07-21 |
20110178183 | Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients - The use of water-soluble or water-dispersible copolymers which are obtained by free radical-initiated polymerization of a mixture of
| 2011-07-21 |
20110178184 | HYDROGEL - A hydrogel comprising a polysaccharide, wherein amphiphilic side chains are bonded to the carboxyl groups of a polysaccharide with carboxyl groups on side chains, an inorganic ion other than calcium ion, and water, and a method for its preparation. The gel has high viscoelasticity, can be injected into the body using an instrument such as a syringe, and is useful for various biomedical materials. | 2011-07-21 |
20110178185 | INTEGRATED BIOREFINERY FOR PRODUCTION OF LIQUID FUELS - A method and system for reforming a carbonaceous feedstock comprising the steps, reforming the feedstock produce a first synthesis gas, subjecting a portion of the first synthesis gas to catalytic conversion, separating from the synthesis gas conversion product at least one byproduct, and utilizing at least a portion of the at least one byproduct during reforming of additional carbonaceous material. In certain instances, the method and system may be used to produce a liquid fuel. | 2011-07-21 |
20110178186 | Preparation Methods for Liquid Hydrocarbons by Fischer-Tropsch Synthesis Through Slurry Reaction - The present invention relates to a method for preparing liquid hydrocarbons via a slurry phase Fischer-Tropsch (F-T) synthesis. In particular, the present invention relates to a method for preparing liquid hydrocarbons from syngas via slurry phase F-T synthesis using a catalyst, which can prevent the decrease in catalyst activity and filter clogging due to catalyst aggrega-tion, simultaneously with improving selectivity for C | 2011-07-21 |
20110178187 | PROCESS AND PLANT FOR PRODUCING METHANOL - For producing methanol from a synthesis gas containing hydrogen and carbon oxides the synthesis gas is passed through a first, preferably water-cooled reactor in which a part of the carbon oxides is catalytically converted to methanol, and the resulting mixture containing synthesis gas and methanol vapor is supplied to a second, preferably gas-cooled reactor in which a further part of the carbon oxides is converted to methanol. The mixture withdrawn from the first reactor is guided through a gas/gas heat exchanger in which the mixture is cooled to a temperature below its dew point. Subsequently, methanol is separated from the gas stream in a methanol separator and withdrawn, while the remaining gas stream is supplied to the second reactor. | 2011-07-21 |
20110178188 | PROCESS AND PLANT FOR PRODUCING METHANOL - For producing methanol from a synthesis gas containing hydrogen and carbon oxides the synthesis gas is passed through a first, water-cooled reactor in which a part of the carbon oxides is catalytically converted to methanol. The resulting mixture containing synthesis gas and methanol vapor is supplied to a second, gas-cooled reactor in which a further part of the carbon oxides is converted to methanol. Subsequently, methanol is separated from the synthesis gas, and synthesis gas is recirculated to the first reactor. The cooling gas flows through the second reactor cocurrent to the mixture withdrawn from the first reactor. | 2011-07-21 |
20110178189 | HYDROCARBON SYNTHESIS PROCESS - This invention relates to a Fischer Tropsch process using a catalyst activated in accordance with the invention. More particularly the invention relates to a three phase Low Temperature Fischer Tropsch process wherein CO and H | 2011-07-21 |
20110178190 | COMB POLYMERS FOR SUPRAMOLECULAR NANOCONFINEMENT - Polymers including pendent hydrophobic groups and pendent proton transfer groups are shown to form nanostructured films exhibiting greatly increased proton conductivity compared with films prepared from corresponding polymers lacking hydrophobic groups. The polymers can include repeating units each of which has both a hydrophobic group and a proton transfer group. Alternatively, the polymers can be the product of copolymerizing a first monomer with at least one hydrophobic group and a second monomer with at least one proton transfer group. The polymers are useful for the preparation of fuel cell proton exchange membranes. | 2011-07-21 |
20110178191 | Devulcanization of Rubber and Other Elastomers - A process for devulcanizing crosslinked elastomer particles comprising applying an alternating radio frequency dielectric field to a composition comprising crosslinked elastomer particles. The alternating radio frequency dielectric field preferably has a frequency between 1 and 100 MHz and a voltage between 1000 and 10,000 V. | 2011-07-21 |
20110178192 | COATING FORMULATION FOR EXPANDABLE PARTICULATE STYRENE POLYMER - A coating formulation intended for expandable particulate styrene polymer and comprising
| 2011-07-21 |
20110178193 | PROCESS FOR PRODUCING ETHYLENE/TETRAFLUOROETHYLENE COPOLYMER POROUS MATERIAL, AND ETHYLENE/TETRAFLUOROETHYLENE COPOLYMER POROUS MATERIAL - To provide a method for easily producing an ethylene/tetrafluoroethylene copolymer porous material having excellent chemical resistance and filtration performance and has a high heat resistance, within a wide range of the porosity, and an ethylene/tetrafluoroethylene copolymer porous material obtained by such a process. | 2011-07-21 |
20110178194 | MODIFIED BLOWING AGENT SURFACE-TREATED WITH METALLIC SILOXYLATED COMPOUND AND POLYMER RESIN COMPOSITION INCLUDING THE SAME - Provided is a modified blowing agent, wherein the surface of a blowing agent powder is coated with a metallic siloxylated compound. When the modified blowing agent is included in a polymer resin, dispersibility of the modified blowing agent is excellent in the polymer resin and fluidity of the polymer resin is improved in an extrusion molding machine and an injection molding machine, and thus productivity and processability can be improved. In addition, the foam that is formed using the polymer resin composition including the modified blowing agent has excellent tear strength, durability, and masking sound properties due to fine and uniform size of foam cells and increased number of foam cells per unit surface area. | 2011-07-21 |
20110178195 | COMPOSITIONS FOR ABRASION RESISTANT FOAMS AND METHODS FOR MAKING THE SAME - The invention provides a composition comprising at least the following components: A) an olefin-based polymer, B) a functionalized polydimethysiloxane, and C) a foaming agent comprising at least one organic compound. | 2011-07-21 |
20110178196 | BIODEGRADABLE POLYMER MIXTURE - The present invention relates to biodegradable polymer mixtures comprising
| 2011-07-21 |
20110178197 | Nonflammable hollow polymeric microspheres - Hollow polymeric microspheres may be rendered nonflammable by coating with one or more flame retardants, while maintaining a composite density of not greater than 0.05 g/cm3. | 2011-07-21 |
20110178198 | POLYMERS MODIFIED BY SILANES - The invention relates to a process for grafting hydrolysable silane groups to a polyolefin, comprising reacting the polyolefin with an unsaturated silane, containing an olefinic —C═C— bond or acetylenic —C≡C— bond and having at least one hydrolysable group bonded to Si, or a hydrolysate thereof, in the presence of means capable of generating free radical sites in the polymer. The silane contains an aromatic ring or a further olefinic double bond or acetylenic unsaturation, the aromatic ring or the further olefinic double bond or acetylenic unsaturation being conjugated with the olefinic —C═C— or acetylenic —C≡C— unsaturation of the silane. The unsaturated silane may also contains electron-withdrawing moiety with respect to the olefinic —C═C— or acetylenic —C≡C— bond. The invention permits to provide a silane-modified polyolefin having a high grafting efficiency while limiting/preventing polymer degradation by chain scission. The silane-modified polyolefin can be further reacted with a polar surface, a filler or a polar polymer or reacted on itself to crosslink the polyolefin and obtain enhanced physical properties of the composites made thereof. | 2011-07-21 |
20110178199 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD - Disclosed herein are a reaction method and a production method of an organic compound which are capable of achieving high reaction selectivity according to the purpose and a high production rate of a target substance. The methods include at least two fluids, wherein at least one kind of the fluids is a fluid containing at least one organic compound and at least one kind of the fluids other than the above fluid is a fluid containing at least one reactant in the form of a liquid or solution, and the respective fluids join together in a thin film fluid foamed between processing surfaces arranged to be opposite to each other so as to be able to approach to and separate from each other, at least one of which rotates relative to the other, whereby an organic reaction is performed in the thin film fluid. | 2011-07-21 |
20110178200 | REACTIVE MESOGENIC COMPOUNDS AND MIXTURES - The invention relates to new reactive mesogenic compounds (RM), polymerisable liquid crystal (LC) mixtures and polymers comprising them, and the use of the compounds, mixtures and polymers in optical, electrooptical, electronic, semiconducting or luminescent components or devices, in decorative, security or cosmetic applications, especially for use in polymer films having high optical dispersion. | 2011-07-21 |
20110178201 | Phospholipid Copolymers - The present disclosure provides copolymers including a first monomer including at least one phospholipid possessing at least one hydroxyl group and a second monomer including a cyclic monomer. Compositions, medical devices, and coatings including such copolymers are also provided. | 2011-07-21 |
20110178202 | VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS - Azo compounds that block visible light are disclosed. These light absorbers are particularly suitable for use in intraocular lens materials. | 2011-07-21 |
20110178203 | HIGH STRENGTH GLUE FORMULATION - A pourable glue formulation is provided. The pourable glue formulation includes a first urethane polymer, wherein the first urethane polymer is operative to provide adequate tensile strength to the formulation; a second urethane polymer, wherein the second urethane polymer is operative to provide adequate flexibility to the formulation; propylene glycol; an ester alcohol; a biocide; a crosslinking agent; a defoamer; and a viscosity modifier. | 2011-07-21 |
20110178204 | COATING COMPOSITION AND METHOD FOR PRODUCING THE SAME, COATING FILM AND UNDERWATER STRUCTURES - Provided are coating composition containing an organic polymer particle (A) composed of an organic polymer having a hydroxyl group and a cationic group in a molecule, the weight average particle size of which being 10 to 35 μm, and a base resin (B), wherein the content of the organic polymer particle (A) is 0.5 to 5.0% by weight in the solid content of the coating composition, and a method of producing the same, and a coating film and underwater structure using the coating composition. The base resin (B) has a group represented by the following general formula (1): | 2011-07-21 |
20110178205 | PROCESS FOR PRODUCING THERMOPLASTIC MOLDING COMPOSITIONS BASED ON STYRENE COPOLYMERS AND POLYAMIDE WITH IMPROVED TOUGHNESS - The invention relates to processes for producing thermoplastic molding compositions, where the thermoplastic molding compositions comprise
| 2011-07-21 |
20110178206 | FLAME RETARDANT POLY(TRIMETHYLENE TEREPHTHALATE) COMPOSITION - Improved flame retardant polytrimethylene terephthalate compositions are provided by including a bis(diphenyl phosphate) flame retardant additive. | 2011-07-21 |
20110178207 | Particle-stabilised emulsions - The invention relates to water-in-oil (W/O) or oil-in-water (O/W) emulsions containing an oil phase of at least one water-insoluble constituent; an aqueous phase; pyrogenic silica at the oil-water interface, the pyrogenic silica partially silylated such that non-silylated surface silanol groups remaining are between 95% and 5% of initial silanol groups, the equivalent of 1.7 to 0.1 surface SiOH groups per nm | 2011-07-21 |
20110178208 | DISPERSANT FOR HYDRAULICALLY SETTING SYSTEMS - Polymers P as dispersants, in particular as liquefiers, for hydraulically setting systems, and hydraulically setting systems including the polymer P. The polymer P includes at least one acid unit, at least one ester unit, and at least one unit containing terephthalate or naphthalate. | 2011-07-21 |
20110178209 | MANUFACTURING HYDRAULIC CEMENT AGGREGATES FOR USE IN INSULATING AND HEAT REFLECTING PRODUCTS - Insulation and heat resistance hydraulic cement aggregates comprising of white Portland cement, with or without additives and filler, magnesium oxide, zirconium compounds, marble, dolomite, granite, sand, talc, clays calcined, boron compounds, silicates, trap rock aggregate, polymeric binder/s optionally water. | 2011-07-21 |
20110178210 | GELLED, FREEZE-DRIED CAPSULES OR AGGLOMERATES OF NANOOBJECTS OR NANOSTRUCTURES, NANOCOMPOSITE MATERIALS WITH POLYMER MATRIX COMPRISING THEM, AND METHODS FOR PREPARATION THEREOF - An agglomerate or capsule capable of being prepared by freeze-drying a first agglomerate or capsule, said first agglomerate comprising a solvent, nanoobjects or nanostructures coated with macromolecules of polysaccharides being homogeneously distributed in said agglomerate or said capsule, and said macromolecules forming in at least one portion of the first agglomerate, a gel by crosslinking with positive ions. | 2011-07-21 |
20110178211 | BIODEGRADABLE POLYESTER RESIN COMPOSITION AND MOLDED BODY COMPOSED OF THE SAME - Disclosed is a biodegradable polyester resin composition, wherein 100 parts by mass of a biodegradable polyester resin is blocked at the terminals thereof with 0.1 to 10 parts by mass of a carbodiimide compound, and the biodegradable polyester resin composition includes 0.1 to 10 parts by mass of a jojoba oil in relation to 100 parts by mass of the biodegradable polyester resin. | 2011-07-21 |
20110178212 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group - The invention relates to a method for producing at least one compound having at least one at least monosubstituted amino group. According to the invention, a starting substance having at least one amino group is reacted with an alcohol in a reaction mixture in the presence of ammonia. | 2011-07-21 |
20110178213 | NUCLEATING AGENTS - A composition includes a thermoplastic polyester or polyolefin; and a nucleant having a chemical formula: | 2011-07-21 |
20110178214 | INK COMPOSITION - An ink jet ink composition containing an aralkyl-modified silicone surfactant, an organic solvent, and a metallic pigment. | 2011-07-21 |
20110178215 | FLAME RETARDANT POLYMER COMPOSITION - A thermoplastic polymer composition that employs a flame retardant formed from a phosphinic compound and organometallic phosphoric compound is provided. The present inventor has discovered that the organometallic phosphoric compound can counteract the tendency of the phosphinic compound to degrade the mechanical properties of the composition when used at certain concentrations. Furthermore, the present inventor has also surprisingly discovered that the organometallic phosphoric compound may itself act as a flame retardant and thus contribute to the overall flamimability performance of the composition. Among other things, this allows compositions to be formed with a lower phosphinic content with the same flammability performance. | 2011-07-21 |
20110178216 | POLYPROPYLENE BASED FORMULATIONS - A polypropylene composition comprising polypropylene impact copolymer or impact modified polypropylene and an effective flame retarding amount of a mixture of (i) tris(tribromoneopentyl) phosphate and (ii) a carbon-carbon initiator, wherein the composition meets a UL 94 rating of V-1 or V-0, said composition being substantially free from antimony trioxide. A method for improving the flame retarding rating of a polypropylene composition is also disclosed. | 2011-07-21 |
20110178217 | POLYVINYL CHLORIDE RESIN COMPOSITION AND METHOD FOR PRODUCING THE SAME - A polyvinyl chloride resin composition contains: from 0.005 to 5 parts by weight of a vinyl alcohol-based polymer containing from 0.01 to 15 mol % of a monomer unit having a specific polyoxyalkylene group in a side chain and having a degree of saponification of from 30 to 99.9 mol %; and from 0.01 to 5 parts by weight of a zinc compound, based on 100 parts by weight of a polyvinyl chloride resin. In addition, a polyvinyl chloride resin composition contains: from 0.005 to 5 parts by weight of a vinyl alcohol-based polymer containing from 0.5 to 18 mol % of an ethylene unit and having a degree of saponification of a vinyl acetate unit of from 30 to 99.9 mol %; and from 0.01 to 5 parts by weight of a zinc compound, based on 100 parts by weight of a polyvinyl chloride resin. A polyvinyl chloride resin composition is thereby provided which is excellent in thermal stability while being shaped and with which a less colored shaped article can be obtained. | 2011-07-21 |
20110178218 | IONIC ORGANIC COMPOUND, PRODUCTION METHOD THEREOF, HYDROGELLING AGENT COMPOSED OF THE IONIC ORGANIC COMPOUND, HYDROGEL CONTAINING SAME, METHANOL GELLING AGENT, METHANOL GEL CONTAINING SAME, AND CARBON NANOTUBE DISPERSANT - Disclosed are a novel ionic organic compound and a method for producing the ionic organic compound by a simple process. Also disclosed are a hydrogelling agent composed of an ionic organic compound obtained by the method, an alcohol gelling agent, a gel which uses the gelling agent, while using water or methanol as a medium, and a carbon nanotube dispersant composed of the compound. Specifically disclosed is an ionic organic compound represented by general formula (1). The compound is obtained by a condensation reaction of (A) an aromatic diamide compound or cyclohexane diamide compound having a 4-(chloromethyl)benzamide group at both ends, and (B) a compound selected from N,N,N′,N′-tetramethylalkylenediamines which may have a substituent wherein there are 1-6 carbon atoms between nitrogen atoms. The thus-obtained ionic organic compound serves as a gelling agent which is capable of gelling a neutral aqueous solution or an alcohol. The solvent solubility can be changed by substituting the anion of the thus-obtained ionic compound with another anion by anion-exchange. (In the formula, A represents a linking moiety having one or more optionally substituted aromatic rings or a linking moiety composed of a cyclohexane ring; B represents a cationic functional group having a quaternized nitrogen atom, which is selected from N,N,N′,N′-tetramethylalkylenediamines which may have a substituent wherein there are 1-6 carbon atoms between nitrogen atoms; X represents a monovalent anion; and n represents an integer of 1-800.) | 2011-07-21 |
20110178219 | POLYMERIZATION METHOD FOR POLYESTER RESIN, POLYESTER RESIN COMPOSITION, AND POLYESTER FILM - A polymerization method for a polyester resin, the method including: an esterification reaction step which includes at least polymerizing an aromatic dicarboxylic acid and an aliphatic diol in the presence of a catalyst containing a titanium compound including an organic chelated titanium complex having an organic acid as a ligand, and adding the organic chelated titanium complex, a magnesium compound, and a pentavalent phosphoric acid ester which does not have an aromatic ring as a substituent, in this order; and a condensation polymerization step of subjecting an esterification reaction product produced by the esterification reaction step to a condensation polymerization reaction. | 2011-07-21 |
20110178220 | Moisture Curable Compositions - A moisture curable composition comprising a polymer (A) containing reactive hydroxyl or hydrolysable groups bonded to silicon, which groups are reactive in the presence of moisture with each other or with groups in a crosslinking agent (B) present in the composition, characterized in that the composition is free from organic compounds of tin and contains kaolin as a catalyst for the reaction of the reactive groups of polymer (A). The kaolin is preferably calcined and most preferably is the only catalyst utilised during cure. | 2011-07-21 |
20110178221 | FLAME RETARDANT POLYETHYLENE COMPOSITION COMPRISING POLYPROPYLENE - The present invention relates to a flame retardant polymer composition comprising (A) a polyethylene, (B) a silicone-group containing compound, (C) an inorganic filler material, and (D) a polypropylene in an amount of 0.1 to 10 wt. % with respect to the total composition, to an article comprising said flame retardant polymer composition, in particular to a wire or cable comprising a layer made of said flame retardant composition and to the use of said flame retardant polymer composition for the production of a layer of a wire or cable. Furthermore, the invention relates to the use of a polypropylene in the production of a flame retardant layer for a wire or cable as a processing aid. | 2011-07-21 |
20110178222 | PROCESS FOR PRODUCING EVOH COMPOSITE - Provided is a composite of saponified product of an ethylene-vinyl ester-based copolymer from which films excellent in gas barrier properties and film rigidity and highly inhibited from having fish eyes are obtained. | 2011-07-21 |
20110178223 | METHOD OF MAKING AN ELASTIC FILM, IN PARTICULAR FOR A HYGIENCI ARTICLE - An elastic film for a hygienic article is made by first premixing polymer components to form a polymer composite that contains styrene block copolymers and then extruding the polymer composite to make at least one layer. During the premixing or the extruding zeolites are added having pores of a size larger than 2.5 Angstrom and smaller than 5.5 Angstrom. | 2011-07-21 |
20110178224 | MULTIFUNCTIONAL GRAPHENE-SILICONE ELASTOMER NANOCOMPOSITE, METHOD OF MAKING THE SAME, AND USES THEREOF - A nanocomposite composition having a silicone elastomer matrix having therein a filler loading of greater than 0.05 wt %, based on total nanocomposite weight, wherein the filler is functional graphene sheets (FGS) having a surface area of from 300 m | 2011-07-21 |
20110178225 | CURABLE RESIN COMPOSITIONS, COATINGS, AND LAMINATED PLASTICS INCLUDING THE SAME - The present invention provides a curable resin composition including: a composite resin (A) in which a polysiloxane segment (a1), which has a structural unit represented by a general formula (1) and/or a general formula (2) as well as having a silanol group and/or a hydrolyzable silyl group, and a vinyl-based polymer segment (a2) having an alcoholic hydroxyl group are bound to each other through a bond represented by a general formula (3); and a polyisocyanate (B), wherein the content of said polysiloxane segment (a1) is from 10 to 60% by weight with respect to the total solid content of the curable resin composition, and the content of the polyisocyanate (B) is from 5 to 50% by weight with respect to the total solid content of the curable resin composition. | 2011-07-21 |
20110178226 | LOW MOLECULAR WEIGHT BROMINATED POLYMERS AND THEIR USE IN THERMOPLASTIC FORMULATIONS - This invention relates flame retardant compositions containing low molecular weight brominated anionic, chain transfer, vinyl aromatic polymers, hereinafter “ACTVAP”. The compositions can accommodate high bromine content while still exhibiting a low thermally labile bromine content. The compositions have glass transition temperatures, Tg, that are predictive of acceptable melt flows and heat distortion temperatures (HDT) in HIPS and ABS based formulations substrates. The compositions, are suitable flame retardant candidates for use in thermoplastic formulations, e.g. polystyrene and ABS formulations. | 2011-07-21 |
20110178227 | NOVEL PRECIPITATED SILICA HAVING PARTICULAR MORPHOLOGY, GRADING AND POROSITY, PREPARATION THEREOF AND REINFORCING OF POLYMERS THEREWITH - Precipitated silicas including clusters of large primary silica particles having at the surface thereof small primary silica particles, have a specific surface area CTAB (S | 2011-07-21 |
20110178228 | RESIN SYRUP, ARTIFICIAL MARBLE CONTAINING A HARDENED FORM OF THE RESIN SYRUP, AND A PRODUCTION METHOD FOR THE SAME - The present invention relates to resin syrup, which comprises a high-molecular-weight acrylic material containing a carboxyl group, and comprises a room-temperature-curing initiator and a high-temperature-curing initiator, and it also relates to an artificial marble containing a hardened form of the resin syrup, and to a production method for the same. The present invention can provide resin syrup having outstanding curing efficiency and a viscosity suitable for press molding by a process such as maturation because of the inclusion of the high-molecular-weight acrylic material containing a carboxyl group, the room-temperature-curing initiator, and the high-temperature-curing initiator, and it can provide an artificial marble containing a hardened form of the resin syrup, and a production method for the same. | 2011-07-21 |
20110178229 | FIBER-REINFORCED RESIN COMPOSITION AND MOLDED BODY THEREOF - Long-fiber-reinforced thermoplastic resin particles and a blend thereof are provided, wherein the opening property of the reinforcing fibers during molding is good, and a molded body exhibiting an excellent appearance and having high mechanical strength is obtained. The particles (A) contains a thermoplastic resin (A1), produced by using a metallocene catalyst, a modified polyolefin resin (A2) modified with an unsaturated carboxylic acid or a derivative thereof, and reinforcing fibers (A3) and satisfy the following requirements (1) to (5); (1) the amount of modification of the unsaturated carboxylic acid or a derivative thereof is 0.01 to 2 percent by weight in 100 percent by weight of the total of (A1) and (A2); (2) (A1) and (A2) constitute 20 to 70 percent by weight in 100 percent by weight of the total of (A1), (A2), and (A3); (3) (A3) constitutes 30 to 80 percent by weight in 100 percent by weight of the total of (A1), (A2), and (A3); (4) when 25 g of (A) is encapsulated in a 20-L chamber and is stood at 65° C. for 1 hour, the amount of acetaldehyde dissipated from (A) is 3.0 μg/m | 2011-07-21 |
20110178230 | POLYVINYL ESTER-BASED LATEX COATING COMPOSITIONS - Embodiments of the present disclosure include a polyvinyl ester-based latex having polyvinyl ester-based particles with vinyl ester groups that have been partially hydrolyzed to a predetermined degree, and methods of modifying and forming the polyvinyl ester-based latex of the present disclosure. Embodiments of the present disclosure also include coating compositions that include the polyvinyl ester-based latex of the present disclosure and an optical brightening agent (OBA), where the polyvinyl ester-based particles act as a carrier for the OBA in a coating composition for a print media substrate. | 2011-07-21 |
20110178231 | Nano-sized hydrogenated diene-based latex particles - The present invention relates to hydrogenated nano-sized diene-based latex particles, a method for their production and their use. | 2011-07-21 |
20110178232 | HEAT-RESISTANT AND HIGH THERMAL CONDUCTIVE ADHESIVE - An object of the present invention is to provide a heat-resistant and high thermal conductive adhesive having excellent mechanical strength, heat resistance, and thermal conductivity. A heat-resistant and high thermal conductive adhesive of the present invention includes: (a) a first component in which a carbon-based filler surface-modified with a first reactive functional group and an adhesive polymer matrix having a second reactive functional group are bonded by an addition condensation reaction of the first reactive functional group and the second reactive functional group; and (b) a second component containing a carbon-based filler surface-modified with a third reactive functional group, wherein the third reactive functional group is a functional group causing an addition condensation reaction with the second reactive functional group by the application of light or heat. | 2011-07-21 |
20110178233 | Elastomer Mixture Mainly Comprising a Diene Elastomer Coupled by an Aminoalkoxysilane Group, Rubber Composition Including the Same and Methods for Obtaining Same - The present invention relates to an elastomer mixture resulting from the modification of a diene elastomer by a coupling agent that introduces, into the elastomer chain, an alkoxysilane group bearing a tertiary or secondary amine functional group. This mixture predominantly comprises the diene elastomer coupled by the alkoxysilane group bearing a tertiary or secondary amine functional group which is bonded to the diene elastomer through the silicon atom. The invention also relates to a reinforced rubber composition, in particular that can be used for the manufacture of tyres, which comprises a reinforcing filler and an elastomer matrix comprising at least this elastomer mixture, and to its preparation process. This composition has improved hysteresis and mechanical properties in the vulcanized state, and also improved processing in the uncured state. | 2011-07-21 |
20110178234 | WATER-BASED RESIN COMPOSITON AND ARTICLES MADE THEREFROM - An aqueous elastomer dispersion includes a dispersed phase and an aqueous phase. The dispersed phase includes an elastomer including curable aliphatic conjugated-diene elastomers, such as polyisoprene, and a minor amount of at least one additive. The aqueous phase includes water and other optional components in either a soluble state or a dispersion state. The aqueous elastomer dispersion may be prepared by dissolving an elastomer, such as rubber, and additives in a solvent mixture and then converting the resulting solution into an aqueous emulsion. The aqueous emulsion is concentrated and the solvent is stripped from it to yield a dilute latex. The dilute latex that is obtained is concentrated again. Articles made from the aqueous elastomer dispersion include medical gloves, condoms, probe covers, dental dams, finger cots, catheters and the like. | 2011-07-21 |
20110178235 | RUBBER COMPOSITION FOR INNER LINER AND PNEUMATIC TIRE - The present invention provides a rubber composition for an inner liner, which can achieve both excellent low heat build-up and high flex crack growth resistance while having processability excellent enough to eliminate the need for mastication, and further has good air impermeability, and also provides a pneumatic tire produced using the rubber composition. The present invention relates to a rubber composition for an inner liner, including: a rubber component that contains a modified natural rubber with a phosphorus content of 200 ppm or less, and carbon black and/or a white filler. | 2011-07-21 |